BioGend Therapeutics6733 
$1.042.10%24h
2.10%24h
Global rank18516
Market cap$127.97M
Change 7d-6.34%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of BioGend Therapeutics (6733)
As of January 2025, BioGend Therapeutics has a market cap of $127.97M. This makes BioGend Therapeutics the world's 18516th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of BioGend Therapeutics from 2019 to 2024
-
Value:-
Market cap history of BioGend Therapeutics from 2019 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $151.31M | 5.10% |
| 2023 | $143.97M | 73.08% |
| 2022 | $83.18M | -17.38% |
| 2021 | $100.69M | -30.34% |
| 2020 | $144.53M | 28.86% |
| 2019 | $112.17M | - |
6733 Market Cap Today is $127.97M 2.10% - 12 Jan 2025
View largest stocks by market cap 
